Signaling crosstalk between tumor endothelial cells and immune cells in the microenvironment of solid tumors
Frontiers in Cell and Developmental Biology · 25.04.2024 · 12
DOI: 10.3389/fcell.2024.1387198 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 25.04.2024. Verfasst von Yuexin Xu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, United States. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Tumor-associated endothelial cells (TECs) are crucial mediators of immune surveillance and immune escape in the tumor microenvironment (TME). TECs driven by angiogenic growth factors form an abnormal vasculature which deploys molecular machinery to selectively promote the function and recruitment of immunosuppressive cells while simultaneously blocking the entry and function of anti-tumor immune cells. TECs also utilize a similar set of signaling regulators to promote the metastasis of tumor cells. Meanwhile, the tumor-infiltrating immune cells further induce the TEC anergy by secreting pro-angiogenic factors and prevents further immune cell penetration into the TME. Understanding the complex interactions between TECs and immune cells will be needed to successfully treat cancer patients with combined therapy to achieve vasculature normalization while augmenting antitumor immunity. In this review, we will discuss what is known about the signaling crosstalk between TECs and tumor-infiltrating immune cells to reveal insights and strategies for therapeutic targeting.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.
- Department of Medicine, Division of Hematology and Oncology, University of Washington, Seattle, WA, United States.
- Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.
- Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, United States.
- Kidney Research Institute, University of Washington, Seattle, WA, United States.
Förderung
- NCI NIH HHS
Zitieren
APA
Xu, Y., Miller, C. P., Tykodi, S. S., Akilesh, S., & Warren, E. H. (2024). Signaling crosstalk between tumor endothelial cells and immune cells in the microenvironment of solid tumors. Frontiers in Cell and Developmental Biology, 12. https://doi.org/10.3389/fcell.2024.1387198
Vancouver
Xu Y, Miller CP, Tykodi SS, Akilesh S, Warren EH. Signaling crosstalk between tumor endothelial cells and immune cells in the microenvironment of solid tumors. Frontiers in Cell and Developmental Biology. 2024;12. doi:10.3389/fcell.2024.1387198
BibTeX
@article{Xu2024,
author = {Xu, Yuexin and Miller, Chris P and Tykodi, Scott S and Akilesh, Shreeram and Warren, Edus H},
title = {Signaling crosstalk between tumor endothelial cells and immune cells in the microenvironment of solid tumors},
journal = {Frontiers in Cell and Developmental Biology},
year = {2024},
volume = {12},
doi = {10.3389/fcell.2024.1387198}
}
EUVIMED